Literature DB >> 8416955

Regulation of morphology by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in Swiss 3T3 cells.

Y Miura1, A Kikuchi, T Musha, S Kuroda, H Yaku, T Sasaki, Y Takai.   

Abstract

rho GDP dissociation inhibitor (GDI) is an inhibitory GDP/GTP exchange protein for a group of small GTP-binding proteins including at least rhoA p21, rhoB p21, rac1 p21, rac2 p21, and G25K. Microinjection of rho GDI into Swiss 3T3 cells made the cells round and refractile. This morphological change was accompanied by the disappearance of stress fibers. The rho GDI action was prevented by comicroinjection of rho GDI with the guanosine 5'-(3-O-thio)triphosphate (GTP gamma S)-bound form of rhoA p21, but not with the GTP gamma S-bound form of rhoA p21 lacking the C-terminal three amino acids, which was not post-translationally modified with lipids. The GTP gamma S-bound form of rac1 p21, the same form of G25K, the same form of smg p21B, or Ki-rasval12 p21 was ineffective. Microinjection of the bacterial ADP-ribosyltransferase C3 specific for rho p21 into Swiss 3T3 cells induced the similar changes of morphology and stress fibers. This C3 action was not prevented by comicroinjection of C3 with the GTP gamma S-bound form of rhoA p21, but was prevented by comicroinjection with the same form of a rhoA p21 mutant which was not ADP-ribosylated by C3. These results indicate that the rho GDI-rho p21 system regulates cell morphology presumably through the actomyosin system in Swiss 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416955

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Rho mediates the shear-enhancement of endothelial cell migration and traction force generation.

Authors:  Yan-Ting Shiu; Song Li; William A Marganski; Shunichi Usami; Martin A Schwartz; Yu-Li Wang; Micah Dembo; Shu Chien
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

2.  TNF-α induces dyscohesion of epithelial cells. Association with disassembly of actin filaments.

Authors:  S Tabibzadeh; Q F Kong; S Kapur; H Leffers; A Ridley; K Aktories; J E Celis
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

3.  Regulation of RhoA signaling by the cAMP-dependent phosphorylation of RhoGDIα.

Authors:  Atsuro Oishi; Noriko Makita; Junichiro Sato; Taroh Iiri
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

4.  Regulation of the Rac1-specific exchange factor Tiam1 involves both phosphoinositide 3-kinase-dependent and -independent components.

Authors:  I N Fleming; A Gray; C P Downes
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

5.  The rat myosin myr 5 is a GTPase-activating protein for Rho in vivo: essential role of arginine 1695.

Authors:  R T Müller; U Honnert; J Reinhard; M Bähler
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

6.  Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.

Authors:  Konstadinos Moissoglu; Kevin S McRoberts; Jeremy A Meier; Dan Theodorescu; Martin A Schwartz
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  Post-translational incorporation of the antiproliferative agent azatyrosine into the C-terminus of alpha-tubulin.

Authors:  Silvia A Purro; C Gastón Bisig; María A Contin; Héctor S Barra; Carlos A Arce
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

8.  The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts.

Authors:  R Kozma; S Ahmed; A Best; L Lim
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

Review 9.  Clostridial ADP-ribosylating toxins: effects on ATP and GTP-binding proteins.

Authors:  K Aktories
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

10.  Constitutive activation of the gastrin-releasing peptide receptor expressed by the nonmalignant human colon epithelial cell line NCM460.

Authors:  H A Ferris; R E Carroll; M M Rasenick; R V Benya
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.